Here are five things both men and women can do to improve diversity and encourage success in IP.
There are key risks to consider before you look to acquire bargain patents from dissolved companies.
A new EPO decision clarifies aspects of its position, but leaves many questions unanswered...
We break down the government's new 'TM Exit Regulations', set to come into play on 'Brexit day'.
Ahead of the 'meaningful vote', here's what will happen to all your IP rights once we leave the EU.
Find out whether you need to put a contingency plan in place for your .eu domain name.
A recent Supreme Court judgement has important implications for pharmaceutical patents.